These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25100046)

  • 1. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline.
    Gankam Kengne F; Couturier BS; Soupart A; Decaux G
    Kidney Int; 2015 Feb; 87(2):323-31. PubMed ID: 25100046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyponatremia: the role of lixivaptan.
    Liamis G; Filippatos TD; Elisaf MS
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):431-41. PubMed ID: 24766294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
    Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
    Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.
    Soupart A; Stenuit A; Perier O; Decaux G
    Clin Sci (Lond); 1991 Jan; 80(1):77-84. PubMed ID: 1846795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.
    Soupart A; Penninckx R; Crenier L; Stenuit A; Perier O; Decaux G
    Kidney Int; 1994 Jan; 45(1):193-200. PubMed ID: 8127009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid correction of hyponatraemia with urea may protect against brain damage in rats.
    Van Reeth O; Decaux G
    Clin Sci (Lond); 1989 Sep; 77(3):351-5. PubMed ID: 2805597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia.
    Baker EA; Tian Y; Adler S; Verbalis JG
    Exp Neurol; 2000 Oct; 165(2):221-30. PubMed ID: 10993682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
    Decaux G; Gankam Kengne F
    Expert Rev Endocrinol Metab; 2020 May; 15(3):195-214. PubMed ID: 32401559
    [No Abstract]   [Full Text] [Related]  

  • 10. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
    Silver SM; Schroeder BM; Sterns RH; Rojiani AM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rapid correction of hyponatremia on the blood-brain barrier of rats.
    Adler S; Verbalis JG; Williams D
    Brain Res; 1995 May; 679(1):135-43. PubMed ID: 7648255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe hyponatremia (<120mEq/l)].
    Decaux G
    Rev Med Brux; 2001 Oct; 22(5):413-9. PubMed ID: 11723783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of symptomatic hyponatremia.
    Decaux G; Soupart A
    Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes are an early target in osmotic demyelination syndrome.
    Gankam Kengne F; Nicaise C; Soupart A; Boom A; Schiettecatte J; Pochet R; Brion JP; Decaux G
    J Am Soc Nephrol; 2011 Oct; 22(10):1834-45. PubMed ID: 21885671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hyponatremia: providing treatment and avoiding harm.
    Vaidya C; Ho W; Freda BJ
    Cleve Clin J Med; 2010 Oct; 77(10):715-26. PubMed ID: 20889809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications.
    Soupart A; Decaux G
    Clin Nephrol; 1996 Sep; 46(3):149-69. PubMed ID: 8879850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microglia in the pathogenesis of osmotic-induced demyelination.
    Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
    Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.
    Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
    J Neuropathol Exp Neurol; 1996 May; 55(5):594-601. PubMed ID: 8627349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the management of acute and chronic hyponatremia.
    Hoorn EJ; Spasovski G
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):424-432. PubMed ID: 31232710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia.
    Abraham WT; Decaux G; Josiassen RC; Yagil Y; Kopyt N; Thacker HP; Mannelli M; Bichet DG; Orlandi C;
    Kidney Int; 2012 Dec; 82(11):1215-22. PubMed ID: 22932122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.